Microbiotica Overview

  • Founded

  • 2016

Founded
  • Status

  • Private

  • Employees

  • 50

Employees
  • Latest Deal Type

  • Series B

  • Latest Deal Amount

  • $69M

  • Investors

  • 6

Microbiotica General Information

Description

Operator of a biotechnology platform intended to discover and develop live bacterial therapeutics and biomarkers. The company's platform focuses on microbiome science to identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to identify phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

Contact Information

Website
www.microbiotica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Chesterford Research Park
  • Little Chesterford
  • Cambridge CB10 1XL
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Microbiotica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 07-Mar-2022 $69M 000.00 00000 Completed Generating Revenue
3. Early Stage VC 24-Oct-2018 00.000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 21-Dec-2017 $6.69M $16.7M 000.00 Completed Generating Revenue
1. Seed Round 15-Dec-2016 $10M $10M 0000 Completed Generating Revenue
To view Microbiotica’s complete valuation and funding history, request access »

Microbiotica Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00.0 00.0 00.0 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00.000
Seed 0,000,000 00.000000 00.0 00.0 00.0 0.000
Seed 7,969,500 $0.000135 $1.35 $1.35 $1.35 22%
Ordinary 30,500 $0.000135 $1.35 $1.35 $1.35 0.08%
To view Microbiotica’s complete cap table history, request access »

Microbiotica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended to discover and develop live bacterial therapeutics and biomarkers. The co
Drug Discovery
Cambridge, United Kingdom
50 As of 2023
000.00
0000 0000-00-00
00000000000 000.00

000000

ugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cu
0000000000000
Cambridge, United Kingdom
000 As of 0000
00000
000000000 00000

0-0000

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000000000000
London, United Kingdom
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Microbiotica Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bicycle Therapeutics Formerly VC-backed Cambridge, United Kingdom 000 00000 000000000 00000
0-000000000000 Formerly VC-backed London, United Kingdom 00 000.00 00000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Microbiotica Patents

  • 20

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Microbiotica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202205055-D0 Therapeutic bacterial composition Pending 06-Apr-2022
GB-202015687-D0 Therapeutic composition Inactive 02-Oct-2020 0000000000
CA-3178982-A1 Bacterial biomarker Pending 19-May-2020 000000000
CA-3178513-A1 Therapeutic bacterial composition Pending 19-May-2020 000000000
EP-4153786-A1 Therapeutic bacterial composition Pending 19-May-2020 A61K35/74
To view Microbiotica’s complete patent history, request access »

Microbiotica Executive Team (8)

Name Title Board Seat Contact Info
Tim Sharpington Chief Executive Officer
Trevor Lawley Ph.D Co-Founder, Board Member & Chief Scientific Officer
Matthew Roe Chief Business Officer
Gordon Dougan Co-Founder
Ronald Carter MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Microbiotica Board Members (9)

Name Representing Role Since
Hans Schikan Self Non-Executive Chairman 000 0000
Mark Quick Flerie Invest Board Member 000 0000
Robert Tansley MD Self Board Member 000 0000
Samuel Williams Ph.D Self Board Member 000 0000
Trevor Lawley Ph.D Microbiotica Co-Founder, Board Member & Chief Scientific Officer 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Microbiotica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Microbiotica Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
British Patient Capital Fund of Funds Minority 000 0000 000000 0
Flerie Invest Venture Capital Minority 000 0000 000000 0
Tencent Venture Capital Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0
Cambridge Innovation Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial